DK0393890T3 - Injicerbart præparat indeholdende 25-cyclohexyl-avermectin B1 - Google Patents

Injicerbart præparat indeholdende 25-cyclohexyl-avermectin B1

Info

Publication number
DK0393890T3
DK0393890T3 DK90303716.6T DK90303716T DK0393890T3 DK 0393890 T3 DK0393890 T3 DK 0393890T3 DK 90303716 T DK90303716 T DK 90303716T DK 0393890 T3 DK0393890 T3 DK 0393890T3
Authority
DK
Denmark
Prior art keywords
preparation containing
injectable preparation
cyclohexyl avermectin
avermectin
cyclohexyl
Prior art date
Application number
DK90303716.6T
Other languages
Danish (da)
English (en)
Inventor
Stephen Richard Wicks
Edward Davison
Original Assignee
Pfizer
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908071A external-priority patent/GB8908071D0/en
Application filed by Pfizer, Pfizer Ltd filed Critical Pfizer
Application granted granted Critical
Publication of DK0393890T3 publication Critical patent/DK0393890T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DK90303716.6T 1989-04-11 1990-04-06 Injicerbart præparat indeholdende 25-cyclohexyl-avermectin B1 DK0393890T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908071A GB8908071D0 (en) 1989-04-11 1989-04-11 Antiparasitic formulations
SG27894A SG27894G (en) 1989-04-11 1994-02-22 Injectable compositions containing 25-cyclohexyl-avermectin B1

Publications (1)

Publication Number Publication Date
DK0393890T3 true DK0393890T3 (da) 1992-09-28

Family

ID=26295191

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90303716.6T DK0393890T3 (da) 1989-04-11 1990-04-06 Injicerbart præparat indeholdende 25-cyclohexyl-avermectin B1

Country Status (16)

Country Link
EP (1) EP0393890B1 (xx)
JP (1) JPH0647548B2 (xx)
CN (1) CN1035356C (xx)
AP (1) AP133A (xx)
AU (1) AU609660B2 (xx)
CY (1) CY1777A (xx)
DK (1) DK0393890T3 (xx)
EG (1) EG18956A (xx)
ES (1) ES2052173T3 (xx)
FI (1) FI92015C (xx)
GR (1) GR3005794T3 (xx)
HK (1) HK39294A (xx)
NO (1) NO175882C (xx)
OA (1) OA09203A (xx)
RU (1) RU1836084C (xx)
SG (1) SG27894G (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
EP0928136B1 (en) * 1996-06-05 2003-10-22 Ashmont Holdings Limited Injectable compositions
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
KR20000025762A (ko) * 1998-10-14 2000-05-06 유충식 이버멕틴류의 가용화 조성물
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
NZ590141A (en) * 2008-06-24 2012-05-25 Merial Ltd Anthelminthic formulations including castor oil and another vegetable oil
CA2750626C (en) * 2009-02-16 2013-10-01 Pfizer Inc. High dosage doramectin formulation
WO2011043962A2 (en) * 2009-10-07 2011-04-14 Wyeth Llc Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1182857B (it) * 1984-09-14 1987-10-05 Glaxo Group Ltd Composti antibiotici, composizioni antiparassitarie che li contengono e procedimento per prepararli ed applicarli
ES8802229A1 (es) * 1985-04-30 1988-04-16 Glaxo Group Ltd Un procedimiento para preparar nuevos derivados lactonicos macrociclicos.
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
EP0285561A3 (de) * 1987-03-27 1989-10-25 Ciba-Geigy Ag Parasitizide und insektizide Milbemycin-Derivate
ATE87926T1 (de) * 1987-11-09 1993-04-15 Pfizer Ethylierte avermectine.

Also Published As

Publication number Publication date
FI92015C (fi) 1994-09-26
RU1836084C (ru) 1993-08-23
FI901816A0 (fi) 1990-04-10
CN1035356C (zh) 1997-07-09
SG27894G (en) 1995-03-17
FI92015B (fi) 1994-06-15
NO175882C (no) 1994-12-28
CY1777A (en) 1995-10-20
NO175882B (no) 1994-09-19
EP0393890A1 (en) 1990-10-24
AU5311990A (en) 1990-11-08
AP9000174A0 (en) 1990-04-30
ES2052173T3 (es) 1994-07-01
JPH02290820A (ja) 1990-11-30
JPH0647548B2 (ja) 1994-06-22
AP133A (en) 1991-06-05
OA09203A (fr) 1992-06-30
GR3005794T3 (xx) 1993-06-07
NO901637D0 (no) 1990-04-10
HK39294A (en) 1994-05-06
CN1046282A (zh) 1990-10-24
EG18956A (en) 1994-04-30
EP0393890B1 (en) 1992-08-12
NO901637L (no) 1990-10-12
AU609660B2 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
BR9007196A (pt) Composicao
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
SE8801813L (sv) Pharmaceutical composition
BR9006919A (pt) Composicao de rimel
KR890701101A (ko) 제약학적 조성물
DE10199066I1 (de) Pharmazeutische Zusammensetzung
DK0399234T3 (da) Ampul
SE9000221D0 (sv) Komposition
DK489189A (da) Farmaceutisk praeparat
BG91785A (bg) Лекарствена форма
DE69027112D1 (de) Impfstoffzusammensetzung
DK540389A (da) Immunstimulerende praeparat
BR9006584A (pt) Composicao de poli-oxi-metileno
DK603988D0 (da) Farmaceutisk praeparat
DK0393890T3 (da) Injicerbart præparat indeholdende 25-cyclohexyl-avermectin B1
BR8902491A (pt) Composicao
DK336489A (da) Farmaceutisk praeparat
DK0381427T3 (da) Vaccinesammensætning
ATA133288A (de) Pharmazeutische zusammensetzung
BR9005424A (pt) Composicao
DK606288D0 (da) Praeparat
DK189289A (da) Substituerede thiourinstoffer
BR8900587A (pt) Composicoes
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
DK343689A (da) Herbicidt praeparat